Drug Trial Radar · NCT01154816
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Last checked: Nov 19, 2026Latest source record: May 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
118
Actual
Start
Feb 2011
Primary completion
Dec 31, 2015
Study completion Jun 30, 2019
Sponsor
- Lead sponsor
- Children's Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jul 1, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial is studying the side effects of and how well alisertib works in treating young patients with relapsed or refractory solid tumors or leukemia. Alisertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Conditions
- Hepatoblastoma
- Previously Treated Childhood Rhabdomyosarcoma
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Myeloid Leukemia
- Recurrent Childhood Kidney Neoplasm
- Recurrent Childhood Malignant Germ Cell Tumor
- Recurrent Childhood Rhabdomyosarcoma
- Recurrent Childhood Soft Tissue Sarcoma
- Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Recurrent Neuroblastoma
- Recurrent Osteosarcoma
Interventions
AlisertibDrug
Given orally
Laboratory Biomarker AnalysisOther
Correlative studies
Pharmacological StudyOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Overall ResponseTime frame: From first dose of alisertib through 6 cycles of protocol therapy or until removal from protocol therapy whichever occurred first.
Locations
105 sites in 2 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Southern California Permanente Medical Group
Downey, California
Miller Children's and Women's Hospital Long Beach
Long Beach, California
Children's Hospital Los Angeles
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
Children's Hospital Central California
Madera, California
Children's Hospital of Orange County
Orange, California
Lucile Packard Children's Hospital Stanford University
Palo Alto, California
Rady Children's Hospital - San Diego
San Diego, California
UCSF Medical Center-Parnassus
San Francisco, California
Connecticut Children's Medical Center
Hartford, Connecticut
Yale University
New Haven, Connecticut
Alfred I duPont Hospital for Children
Wilmington, Delaware
Children's National Medical Center
Washington D.C., District of Columbia
Lee Memorial Health System
Fort Myers, Florida
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida
Florida Hospital Orlando
Orlando, Florida
Nemours Children's Clinic - Orlando
Orlando, Florida
UF Cancer Center at Orlando Health
Orlando, Florida
Nemours Children's Clinic - Pensacola
Pensacola, Florida
All Children's Hospital
St. Petersburg, Florida
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida
Children's Healthcare of Atlanta - Egleston
Atlanta, Georgia
University of Hawaii Cancer Center
Honolulu, Hawaii
Lurie Children's Hospital-Chicago
Chicago, Illinois
University of Illinois
Chicago, Illinois
University of Chicago Comprehensive Cancer Center
Chicago, Illinois
Saint Jude Midwest Affiliate
Peoria, Illinois
Southern Illinois University School of Medicine
Springfield, Illinois
Indiana University/Melvin and Bren Simon Cancer Center
Indianapolis, Indiana
Riley Hospital for Children
Indianapolis, Indiana
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa
University of Kentucky/Markey Cancer Center
Lexington, Kentucky
Tulane University Health Sciences Center
New Orleans, Louisiana
Sinai Hospital of Baltimore
Baltimore, Maryland
Johns Hopkins University/Sidney Kimmel Cancer Center
Baltimore, Maryland
Dana-Farber Cancer Institute
Boston, Massachusetts
Showing 40 of 105 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.